Jennifer K. Simpson Cytrx Corp (CYTR) insider trading activity

Jennifer K. Simpson is Director of CYTRX CORP. Currently has a direct ownership of 25,000 shares of CYTR, which is worth approximately $0. The most recent transaction as insider was on Dec 15, 2021, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25K

0% 3M change

0% 12M change

Total Value Held $0

Jennifer K. Simpson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 15 2021	BUY Grant, award, or other acquisition	-	25,000 Added 50.0%	25,000 Common Stock

Also insider at

EGRX

EAGLE PHARMACEUTICALS, INC. Healthcare

Director

PBLA

Panbela Therapeutics, Inc. Healthcare

President and CEO

JKS